Skyepharma PLC announces Research Update

marketwire.com     20-May-2008            

LONDON--(Marketwire - May 20, 2008) - SkyePharma Announces Presentation of FlutiformTM Phase III Safety Study at ATS in Toronto LONDON, UK, 20 May, 2008 - SkyePharma PLC (LSE: SKP) today announces the presentation of its Phase III, long-term, open label safety study evaluating FlutiformTM for the... [read full story]                    


*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies